Track topics on Twitter Track topics that are important to you
Raj K. Maturi
NEW ORLEANS — No overall difference was found in mean visual acuity gains in patients treated with Lucentis alone or with Lucentis plus dexamethasone, according to a speaker.
“We wanted to evaluate if a combination treatment would be superior to anti-VEGF treatment alone for patients with persistent edema,” Raj K. Maturi, MD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting, where he delivered results of the Diabetic Retinopathy Clinical Research Network Protocol U trial.
“We enrolled 236 eyes, gave them three
Original Article: Protocol U: No overall difference between single, combined treatmentsNEXT ARTICLE
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...